Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor

Blood

Volumn 101, Issue 4, 2003, Pages 1316-1323

  Casella, Ida ^b   Feccia, Tiziana ^b   Chelucci, Cristiana ^b   Samoggia, Paola ^b   Castelli, Germana ^b   Guerriero, Raffaella ^b   Parolini, Isabella ^b   Petrucci, Eleonora ^b   Pelosi, Elvira ^b   Morsilli, Ornella ^b   Gabbianelli, Marco ^b   Testa, Ugo ^b   Peschle, Cesare ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GROWTH FACTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; ERYTHROCYTE; HEMATOPOIESIS; MEGAKARYOCYTE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; STEM CELL;

EID: 0037441869     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2184     Document Type: Article

References (56)

1. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 1995;86:419-431.
2. Zucker-Franklin D, Kaushansky K. Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis. Blood. 1996;88:1632-1638.
3. Zimmet J, Ravid K, Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol. 2000;28:3-16.
4. Cramer EM, Norol F, Guichard J, et al. Ultrastructure of platelet formation by human megakaryocytes culture with the Mpl ligand. Blood. 1997;89:2336-2346.
5. + cells. Blood. 1998;91:830-843.
6. Williams J-L, Pipia G-G, Datta N-S, Long M-W. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood. 1998;91:4118-4126.
7. Guerriero R, Mattia G, Testa U, et al. SDF-1α increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood. 2001;97:2587-2595.
8. Muta K, Krantz S-B, Bondurant M-C, Wickrema A. Distinct roles of erythropoietin, insulin-like growth factor 1, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest. 1994;94:34-43.
9. Ferrara N. Vascular endothelial growth factor: molecular and biological aspect. Curr Top Microbiol Immunol. 1999;237:1-30.
10. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.
11. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 2000;60:203-212.
12. Gale N-W, Yancopoulos G-D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999;13:1055-1066.
13. Persico M-G, Vincenti V, Di Palma T. Structure, expression and receptor-binding properties of placenta growth factor (PIGF). Curr Top Microbiol Immunol. 1999;237:31-40.
14. Petrova P-V, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor receptors. Exp Cell Res. 1999;253:117-130.
15. Leung D-W, Cachlanes G, Kuang W-J, Goeddel D, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
16. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
17. Fong G-J, Rossant J, Gertsenstein M, Breitman M-L. Role of the Flt1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376:66-70.
18. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442.
19. Carmeliet P, Ferreira V, Breler G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435-439.
20. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376:62-66.
21. Shalaby F, Ho J, Stanford WL, et al. A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 1997;89:981-990.
22. Larsson-Blomberg L, Dzierzak E. Isolation of tyrosine kinase related genes expressed in the early hematopoietic system. FEBS Lett. 1994;348:119-125.
23. Katoh O, Tauchi H, Kawalshi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 1995;55:5687-5692.
24. Oyama T, Rau S, Ishida T, et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 1998;160:1224-1232.
25. Ziegler B-L, Valtieri M, Almeida Porada G, et al. KDR receptor: a key marker defining hematopoietic stem cells. Science. 1999;285:1553-1558.
26. + cells identifies a population of functional endothelial precursors. Blood. 2000;95:952-958.
27. Pelosi E, Valtieri M, Coppola S, et al. Identification of the hemangioblast in post-natal life. Blood. 2002;100:3203-3208.
28. Ratajczak MZ, Ratajczak J, Machalinski B, et al. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulating human haemopoietic cell growth. Br J Haematol. 1998;103:969-979.
29. Sawano A, Iwai S, Sakurai Y, et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocytemacrophages in humans. Blood. 2001;97:785-790.
30. Barleon B, Sozzani S, Zhou D, Welch H-A, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via VEGF receptor flt-1. Blood. 1999;87:3336-3343.
31. Möhle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombininduced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A. 1997;94:663-668.
32. Tordjman R, Delaire S, Plouet J, et al. Erythroblasts are a source of angiogenic factors. Blood. 2001;97:1968-1974.
33. Bobik R, Hong Y, Breier G, Martin JF, Erusalimsky JD. Thrombopoietin stimulates VEGF release from c-mpl-expressing cell lines and haemopoietic progenitors. FEBS Lett. 1998;423:10-14.
34. Testa U, Fossati C, Samoggla P, et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood. 1996;88:3391-3406.
35. Condorelli GL, Testa U, Valtieri M, et al. Modulation of retinoblastoma gene in normal adult hematopoiesis: peak expression and functional role in advanced erythroid differentiation. Proc Natl Acad Sci U S A. 1995;92:4808-4812.
36. Gabbianelli M, Pelosi E, Montesoro E, Testa U, Peschle C. Multi-level effects of FLT3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood. 1995;86:1661-1670.
37. Guerriero R, Testa U, Gabbianelli M, et al. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood. 1995;86:3725-3736.
38. Ziegler B, Testa U, Condorelli G, Vitelli L, Valtieri M, Peschle C. Unilineage hematopoietic differentiation in bulk and single cell culture. Stem Cells. 1998;6:51-73.
39. + bone marrow cells) are enriched with megakaryocytes expressing CD4. Blood. 1996;87:1353-1360.
40. Ishidowa Y, Ito T. Kinetics of hemopoiesis in a hypoxic culture. Eur J Hematol. 1998;40:126-129.
41. Keller MR, Bender JG, Miller WM, Papoutsakis ET. Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow. Exp Hematol. 1992;20:264-270.
42. Adelman D-M, Maltepe E, Simon M-C. Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev. 1999;13:2478-2483.
43. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene. 2002;21:3359-3367.
44. Jackson CW, Simone JV, Edwards CC. The relationship of anemia and thrombocytosis. J Lab Clin Med. 1974;84:357-368.
45. McDonald TP, Cottrel MB, Steward SA, et al. Comparison of platelet production in two strains of mice with different modal megakaryocyte DNA ploidies after exposure to hypoxia. Exp Hematol. 1992;20:51-56.
46. Jackson CW, Edwards CC. Biphasic thrombocytopenic response to severe hypobaric hypoxia. Br J Haematol. 1977;35:233-244.
47. Karpatkin S, Garg SK, Freedman ML. Role of iron as a regulator of thrombopoiesis. Am J Med. 1974;57:521-525.
48. McDonald TP, Cottrel MB, Clift R. Effects of shortterm hypoxia on platelet counts in mice. Blood. 1978;51:165-175.
49. Asano M, Kaneoka K, Nomura T, et al. Increase in serum vascular endothelial growth factor levels during altitude training. Acta Physiol Scand. 1998;162:455-459.
50. Hudson JG, Bowen AL, Navia P, et al. The effect of high altitude on platelet counts, thrombopoietin and erythropoetin levels in young Bolivian airmen visiting the Andes. Int J Biometeorol. 1999;43:85-90.
51. Racke F-K, Lewandowska K, Guoeli S, Goldfarb N-J. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated pathway is required for megakaryocytic differentiation of K562. Biol Chem. 1997;272:23366-23370.
52. Rojnuckarin P, Drachman J-G, Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood. 1999;94:1273-1282.
53. Fichelson S, Freyssinier JM, Picard F, et al. Megakaryocyte growth and development factorinduced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood. 1999;94:1601-1613.
54. Geraber HP, Malik AK, Solar GP, et al. VEGF regulates hematopoietic stem cell survival by an internal autocrine loop mechanism. Nature. 2002;417:954-958.
55. Gabrilovich D, Ishida T, Oyama T, et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood. 1998;92:4150-4166.
56. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;9:1005-1014.